Cytodyn Inc Revenue Growth Rates (CYDY), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Cytodyn inc   (CYDY)
 

CYDY's Revenue Growth by Quarter and Year

Cytodyn Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CYDY Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter May -4.22
3rd Quarter February 0.00
2nd Quarter November 0.00
1st Quarter August 0.00
FY -4.22

CYDYs Annual Revenue
Cytodyn Inc 's Revenue in the fiscal year 2026 $ 0.00 millions
Cytodyn Inc 's Revenue in the fiscal year 2025 $ 0.00 millions
Cytodyn Inc 's Revenue in the fiscal year 2024 $ 0.00 millions
Cytodyn Inc 's Revenue in the fiscal year 2023 $ 0.00 millions
Cytodyn Inc 's Revenue in the fiscal year 2022 $ 0.27 millions




CYDY Revenue fourth quarter 2025 Y/Y Growth Comment
Cytodyn inc in the fourth quarter 2025 recorded of $ -4.22 millions.

According to the results reported in the fourth quarter 2025, Cytodyn Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Cytodyn Inc ' s Revenue no change of 0% ranks overall at the positon no. in the fourth quarter 2025.


CYDY Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter May - - - -
3rd Quarter February - - - -
2nd Quarter November - - - -
1st Quarter August - - - -
FY   - - - -

Financial Statements
Cytodyn Inc 's fourth quarter 2025 Revenue $ -4.22 millions CYDY's Income Statement
Cytodyn Inc 's fourth quarter 2024 Revenue $ 0.00 millions Quarterly CYDY's Income Statement


CYDY Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter May - - - -
3rd Quarter February - - - -
2nd Quarter November - - - -
1st Quarter August - - - -
FY (Year on Year)   - - - -


Back to CYDY Growth rate Comparisons >> Back to CYDY Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Cytodyn Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CYDY's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CYDY's IV. Quarter Q/Q Revenue Comment


Cytodyn Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(May 31 2026)		 12 Months Ending
(Feb 28 2026)		 12 Months Ending
(Nov 30 2025)		 12 Months Ending
(Aug 31 2025)		 12 Months Ending
(May 31 2025)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the May 31 2026 period, Cytodyn Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Cytodyn inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the May 31 2026 period, Cytodyn Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Cytodyn inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CYDY's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending May 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending May 31 2026
Neogen Corporation-0.58%$ -0.581 millions
Cryo cell International Inc -1.93%$ -1.926 millions
Nurix Therapeutics Inc -79.47%$ -79.474 millions


About Cytodyn Inc Revenue Growth Rates (CYDY), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Cytodyn Inc (CIK 1175680).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001175680-26-000014
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Cytodyn Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.